No photo of Angela Hawken

Angela Hawken

Professor of Public Policy, Marron Institute

    19982019
    If you made any changes in Pure, your changes will be visible here soon.

    Fingerprint Weighted list of dominant concepts in the researcher's publications (titles and abstracts).

    • 5 Similar Profiles
    Cannabis Medicine & Life Sciences
    Criminal Law Medicine & Life Sciences
    Crime Medicine & Life Sciences
    Pharmaceutical Preparations Medicine & Life Sciences
    National Institute on Drug Abuse (U.S.) Medicine & Life Sciences
    Substance-Related Disorders Medicine & Life Sciences
    Research Personnel Medicine & Life Sciences
    drug policy Social Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output 1998 2019

    Open Access
    Cannabis
    Safety

    Economic Implications of HOPE from the Demonstration Field Experiment

    Hawken, A., Nov 1 2018, In : Criminology and Public Policy. 17, 4, p. 901-906 6 p.

    Research output: Contribution to journalArticle

    experiment
    economics
    Experiment
    Economics

    Celerity and Deterrence

    Hawken, A. & Kleiman, M., 2017, (Accepted/In press) Deterrence, Choice, and Crime: Contemporary Perspectives. Cullen, F., Jonson, C. L. & Nagin, D. (eds.). New Brunswick, NJ: Transaction

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

    Comparing Policies across Different Drug Markets

    Hawken, A., 2017, (Accepted/In press) Dual Markets—Comparative Approaches for Regulation. Savona, E. U. & Kleiman, M. A. R. (eds.). Berlin: Springer

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

    Comparing policies across US drug markets

    Hawken, A., Nov 14 2017, Dual Markets: Comparative Approaches to Regulation. Springer International Publishing, p. 181-190 10 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    drug
    Costs and Cost Analysis
    market
    regulation
    costs